Pavel Lagutin enters the ITF M25 Idanha-a-Nova round-of-16 matchup as the higher-ranked player at approximately ATP 562, compared to Rafael Izquierdo Luque near 719-722. Lagutin arrives with strong recent momentum after defeating Rodrigo Fernandes in straight sets on the same hard-court surface in the prior round. Izquierdo Luque's form has been less consistent, including a recent straight-sets loss in another M25 event. Both competitors have limited prior head-to-head history at this level, making current ranking, recent results, and hard-court adaptation the primary drivers of trader consensus on implied probabilities for the outcome. No notable injuries or withdrawals have been reported ahead of the August 13 contest.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoPavel Lagutin – Rafael Izquierdo Luque
Moneyline
$1.5K Vol.
This market will resolve to 'Pavel Lagutin' if Pavel Lagutin advances against Rafael Izquierdo Luque.
This market will resolve to 'Rafael Izquierdo Luque' if Rafael Izquierdo Luque advances against Pavel Lagutin.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one player advances due to the opponent's retirement, default, or disqualification, this market will resolve to the player who advances.
If the match ends in a walkover (player withdraws before the start and the other advances automatically), this market will resolve to 50-50.
The primary resolution source will be official information from the International Tennis Federation (ITF). A consensus of credible reporting may also be used.
Mercado Aberto: Aug 13, 2026, 2:14 AM ET
Fonte de resolução
https://www.itftennis.com/en/tournament-calendar/Resolver
0x65070BE91...Pavel Lagutin – Rafael Izquierdo Luque
Moneyline
$1.5K Vol.
This market will resolve to 'Pavel Lagutin' if Pavel Lagutin advances against Rafael Izquierdo Luque.
This market will resolve to 'Rafael Izquierdo Luque' if Rafael Izquierdo Luque advances against Pavel Lagutin.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one player advances due to the opponent's retirement, default, or disqualification, this market will resolve to the player who advances.
If the match ends in a walkover (player withdraws before the start and the other advances automatically), this market will resolve to 50-50.
The primary resolution source will be official information from the International Tennis Federation (ITF). A consensus of credible reporting may also be used.
Mercado Aberto: Aug 13, 2026, 2:14 AM ET
Fonte de resolução
https://www.itftennis.com/en/tournament-calendar/Resolver
0x65070BE91...Pavel Lagutin enters the ITF M25 Idanha-a-Nova round-of-16 matchup as the higher-ranked player at approximately ATP 562, compared to Rafael Izquierdo Luque near 719-722. Lagutin arrives with strong recent momentum after defeating Rodrigo Fernandes in straight sets on the same hard-court surface in the prior round. Izquierdo Luque's form has been less consistent, including a recent straight-sets loss in another M25 event. Both competitors have limited prior head-to-head history at this level, making current ranking, recent results, and hard-court adaptation the primary drivers of trader consensus on implied probabilities for the outcome. No notable injuries or withdrawals have been reported ahead of the August 13 contest.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoCuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions
Montar um combo
Escolha duas opções
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions